Roche (RHHBY) News Today $41.09 +0.02 (+0.05%) As of 06/11/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesInsider TradesOwnershipShort InterestBuy This Stock RHHBY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Roche’s Chugai Seeks Next Milestone after Finding Success with Eli Lilly’s Obesity DrugJune 11 at 12:46 PM | theglobeandmail.comRoche Holding AG (OTCMKTS:RHHBY) Shares Bought by Bard Financial Services Inc.Bard Financial Services Inc. boosted its position in shares of Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 25.3% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 138,900 shares of the company's stock afterJune 11 at 7:42 AM | marketbeat.comAccess Medical Labs, a Subsidiary of Empresas Aries, Completes Historic Lab Expansion with Roche Diagnostics SystemsJune 10 at 12:10 PM | globenewswire.com$101.5 Bn Oncology Diagnostics Global Markets, 2023-2024 & 2025-2029 with Profiles of Leading Players - F. Hoffmann-La Roche.June 10 at 6:19 AM | globenewswire.comGreen Steel Industry Report 2025-2029 with Profiles of Leading Players - F. Hoffmann-La Roche.June 10 at 5:44 AM | globenewswire.comHealth Rounds: Roche's Tecentriq reduces recurrence, deaths for certain colon cancer patientsJune 6, 2025 | reuters.comGAMMA Investing LLC Grows Position in Roche Holding AG (OTCMKTS:RHHBY)GAMMA Investing LLC boosted its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 6,463.8% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 528,778 shares of the company's stock after purchasing an additional 520,722 shares during thJune 6, 2025 | marketbeat.comRoche’s Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)June 4, 2025 | finance.yahoo.comRoche's Evrysdi tablet approved by European Commission as first and only for Spinal Muscular Atrophy (SMA)June 4, 2025 | globenewswire.comRoche Holding AG (OTCMKTS:RHHBY) Short Interest Up 35.0% in MayRoche Holding AG (OTCMKTS:RHHBY - Get Free Report) was the recipient of a significant increase in short interest in May. As of May 15th, there was short interest totalling 5,810,300 shares, an increase of 35.0% from the April 30th total of 4,303,900 shares. Currently, 0.1% of the company's stock are short sold. Based on an average daily volume of 4,822,800 shares, the short-interest ratio is presently 1.2 days.June 3, 2025 | marketbeat.comRoche's Tecentriq With Lurbinectedin Increases Survival to Small-Cell Lung Cancer, Study SaysJune 3, 2025 | wsj.comRoche's Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancerJune 3, 2025 | globenewswire.comGenentech's Tecentriq Combined with Lurbinectedin Shows Significant Survival Benefit in Extensive-Stage Small Cell Lung CancerJune 2, 2025 | businesswire.comNew Data Show Genentech's Itovebi Significantly Extended Survival in a Certain Type of HR-positive Advanced Breast CancerMay 31, 2025 | businesswire.comNew data show Roche's Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancerMay 31, 2025 | globenewswire.comBoston Common Asset Management LLC Purchases 29,522 Shares of Roche Holding AG (OTCMKTS:RHHBY)Boston Common Asset Management LLC raised its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 10.0% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 325,732 shares of the company's stock after buying anMay 30, 2025 | marketbeat.comGenentech's Fenebrutinib Maintains Near-Complete Suppression of Disease Activity and Disability Progression for up to Two Years in People With Relapsing Multiple SclerosisMay 30, 2025 | businesswire.comTop Analyst Reports for Alphabet, Bank of America & RocheMay 28, 2025 | msn.comRoche extends trials of antibiotic against resistant superbug, FT reportsMay 28, 2025 | yahoo.comTandem Diabetes, Roche enter patent settlement agreementMay 26, 2025 | finance.yahoo.comRoche moves antibiotic against superbug into Phase 3 of testingMay 26, 2025 | reuters.comRoche Holding AG (OTCMKTS:RHHBY) Given Consensus Recommendation of "Hold" by BrokeragesShares of Roche Holding AG (OTCMKTS:RHHBY - Get Free Report) have earned an average recommendation of "Hold" from the eight analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell rating, three have issued a hold rating, one haMay 25, 2025 | marketbeat.comTandem to pay Roche $36M in patent dispute settlementMay 23, 2025 | msn.comRoche Gets Positive Opinion For Approval Of Cancer Therapy In EU: Retail Yet To ReactMay 23, 2025 | msn.comCHMP recommends EU approval of Roche’s Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancerMay 23, 2025 | finance.yahoo.comRoche wins EU endorsement for metastatic breast cancer treatmentMay 23, 2025 | msn.comCHMP recommends EU approval of Roche's Itovebi for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancerMay 23, 2025 | globenewswire.comOrionis Biosciences partners with Roche's Genentech for oncology therapiesMay 23, 2025 | msn.comNew two-year follow-up of Roche’s Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patientsMay 23, 2025 | finance.yahoo.comRoche announces new collaboration with Broad Clinical Labs to accelerate adoption of cutting-edge SBX sequencing technologyMay 23, 2025 | globenewswire.comNew Two-year Follow-up of Genentech's Columvi Extends Overall Survival in Relapsed or Refractory Diffuse Large B-cell Lymphoma PatientsMay 23, 2025 | businesswire.comNew two-year follow-up of Roche's Columvi extends overall survival in relapsed or refractory diffuse large B-cell lymphoma patientsMay 23, 2025 | globenewswire.comFDA approves Roche’s Susvimo for diabetic retinopathyMay 22, 2025 | finance.yahoo.comFDA Approves Genentech's Susvimo for Diabetic RetinopathyMay 22, 2025 | businesswire.comFDA approves Roche's Susvimo for diabetic retinopathyMay 22, 2025 | globenewswire.comRoche unit Genentech in pact with Orionis for cancer therapiesMay 21, 2025 | msn.comGenentech's Columvi label expansion gets negative vote by FDA committeeMay 20, 2025 | msn.comGenentech Provides Update on FDA Advisory Committee Meeting on Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell LymphomaMay 20, 2025 | businesswire.comRoche provides update on FDA Advisory Committee meeting on Columvi combination for people with relapsed or refractory diffuse large B-cell lymphomaMay 20, 2025 | globenewswire.comIs TIGIT Still A Valid Target In Lung Cancer Patients? Arcus May Be Next To FailMay 19, 2025 | seekingalpha.comBerenberg Bank Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)May 18, 2025 | theglobeandmail.comRoche (OTCMKTS:RHHBY) Shares Unloaded Rep. Bruce WestermanRepresentative Bruce Westerman (R-Arkansas) recently sold shares of Roche Holding AG (OTCMKTS:RHHBY). In a filing disclosed on May 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Roche stock on April 21st. The trade occurred in the Representative's "FISHER IRA" aMay 16, 2025 | marketbeat.comRFK Jr. aide: GLP-1 weight loss meds will cost the same as in least expensive countriesMay 16, 2025 | msn.comMinot DeBlois Advisors LLC Invests $752,000 in Roche Holding AG (OTCMKTS:RHHBY)Minot DeBlois Advisors LLC bought a new position in Roche Holding AG (OTCMKTS:RHHBY - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 21,554 shares of the company's stock, valued at approximateMay 15, 2025 | marketbeat.comRoche receives FDA approval for the VENTANA MET (SP44) RxDx Assay as the first companion diagnostic to identify non-squamous non-small cell lung cancer patients eligible for treatment with EmrelisMay 14, 2025 | globenewswire.comRoche: APHINITY Trial Shows Significant Improvement Of Overall SurvivalMay 14, 2025 | nasdaq.comRoche warns Trump's drug price order puts US investment at riskMay 14, 2025 | finance.yahoo.comRoche reportedly warns Trump’s executive order can risk its U.S. investmentsMay 14, 2025 | msn.comTrump's drug pricing order threatens Roche's $50 billion US investment plans, company saysMay 14, 2025 | reuters.comTen-Year APHINITY Data Show Genentech’s Perjeta-based Regimen Reduced the Risk of Death by 17% in HER2-Positive Early-Stage Breast CancerMay 13, 2025 | uk.finance.yahoo.com Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address RHHBY Media Mentions By Week RHHBY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RHHBY News Sentiment▼0.321.01▲Average Medical News Sentiment RHHBY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RHHBY Articles This Week▼78▲RHHBY Articles Average Week Get Roche News Delivered to You Automatically Sign up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies China Construction Bank News Airbus News EssilorLuxottica Société anonyme News Iberdrola News Nintendo News BNP Paribas News Vinci News Atlas Copco News Compass Group News Japan Tobacco News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:RHHBY) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Roche With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RHHBY Stock Free RHHBY Stock Alerts